Biogen Idec (NASDAQ:BIIB) signed a contract with Isis Pharmaceuticals Inc. to research and create antisense drugs next to three unrevealed targets to cure neurological or neuromuscular illnesses that could observe Isis get more than $230 million. The pact is the …
↧
Biogen Idec (NASDAQ:BIIB) Joins Hand with Isis Over Antisense Drugs Development – ACUR, JNJ, MRK, HCA, AMRN, DNDN, BIIB, PFE, CELG
↧